Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary Shares, nominal value of $0.01 per share
-
Shares outstanding
-
2,461,355,158
-
Total 13F shares
-
243,277
-
Share change
-
+53,465
-
Total reported value
-
$990,304
-
Price per share
-
$4.07
-
Number of holders
-
11
-
Value change
-
+$226,732
-
Number of buys
-
6
-
Number of sells
-
3
Institutional Holders of Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) as of Q4 2023
As of 31 Dec 2023,
Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
243,277 shares.
The largest 10 holders included
Exome Asset Management LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Activest Wealth Management, JPMORGAN CHASE & CO, Pineridge Advisors LLC, ROYAL BANK OF CANADA, and MORGAN STANLEY.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.